A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia
Completed · Phase 1 · Has a placebo group
Conditions studied: Schizophrenia
In brief
A Clinical Study to learn if SEP-363856 has physical dependence in adults with schizophrenia. This study will be held in approximately 6 study sites in the United States. It will be accepting male and female participants age 18 years to 65 years. Participation will be up to approximately10 weeks.
Key facts
- Study ID
- NCT05848700
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- People needed
- 60
- Starts
- 2023-06-21
- Expected to finish
- 2024-03-15
- Last updated by the study team
- 2024-06-26
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Woodland International Research Group, LLC — Little Rock, Arkansas, United States
- Woodland Research Northwest — Rogers, Arkansas, United States
- Behavioral Clinical Research, Inc — Miami Lakes, Florida, United States
- Research Centers of America at Fort Lauderdale Behavioral Health Center — Oakland Park, Florida, United States
- Atlanta Center for Medical Research — Atlanta, Georgia, United States
- Neuro-Behavioral Clinical Research, Inc — North Canton, Ohio, United States
- Pillar Clinical Research, LLC — Richardson, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.